Alzamend Neuro, Inc.

Ownership Transactions Reported by 11 Insiders

Symbol: ALZN on Nasdaq
Industry: Pharmaceutical Preparations
Location: 3500 Lenox Rd. Ne, Suite 1500, Atlanta, GA

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+9.03K	93.1%	$0.98	+$8.85K
Sells	1	-666	6.9%	$0.88	-$587
Net	0	+8.37K	86.3%		+$8.26K

Alzamend Neuro, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
William B. Horne	Director	$1.02M			Feb 24, 2023
Milton C. Ault III	Director, 10%+ Owner	$134K	+$8.85K	+7.09%	Aug 6, 2024
Jeffrey Oram	Director	$102K			Mar 15, 2022
Andrew H. Woo	Director	$102K			Mar 15, 2022
David J. Katzoff	Chief Financial Officer	$82.5K			Sep 26, 2023
Mark Gustafson	Director	$61.1K			Mar 31, 2022
Stephan Jackman	Chief Executive Officer, Director	$46.3K			Apr 28, 2023
Lynne F. McGrath	Director	$3.44K	-$587	-14.6%	Apr 30, 2024
Henry Carl Nisser	Exec VP and General Counsel, Director				Jun 14, 2021
Lien Escalona	Chief Financial Officer				Jun 14, 2021
Kenneth S. Cragun	SVP of Finance				Nov 30, 2022

Recent Insider Transactions by Companies or Individuals for Alzamend Neuro, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.